HRP20020918A2 - Sulfonamide derivatives - Google Patents
Sulfonamide derivatives Download PDFInfo
- Publication number
- HRP20020918A2 HRP20020918A2 HR20020918A HRP20020918A HRP20020918A2 HR P20020918 A2 HRP20020918 A2 HR P20020918A2 HR 20020918 A HR20020918 A HR 20020918A HR P20020918 A HRP20020918 A HR P20020918A HR P20020918 A2 HRP20020918 A2 HR P20020918A2
- Authority
- HR
- Croatia
- Prior art keywords
- compound
- formula
- image
- phenyl
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20600300P | 2000-05-19 | 2000-05-19 | |
| PCT/US2001/011747 WO2001090057A1 (en) | 2000-05-19 | 2001-05-04 | Sulfonamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20020918A2 true HRP20020918A2 (en) | 2004-02-29 |
Family
ID=22764580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20020918A HRP20020918A2 (en) | 2000-05-19 | 2001-05-04 | Sulfonamide derivatives |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030225163A1 (es) |
| EP (1) | EP1311474A1 (es) |
| JP (1) | JP2003534316A (es) |
| KR (1) | KR20030007644A (es) |
| CN (1) | CN1429205A (es) |
| AR (1) | AR035915A1 (es) |
| AU (1) | AU2001259053A1 (es) |
| BR (1) | BR0110874A (es) |
| CA (1) | CA2409830A1 (es) |
| CZ (1) | CZ20023797A3 (es) |
| DZ (1) | DZ3343A1 (es) |
| EA (1) | EA200201234A1 (es) |
| EC (1) | ECSP014078A (es) |
| HR (1) | HRP20020918A2 (es) |
| HU (1) | HUP0302255A3 (es) |
| IL (1) | IL152156A0 (es) |
| MX (1) | MXPA02010020A (es) |
| NO (1) | NO20025459D0 (es) |
| PE (1) | PE20020052A1 (es) |
| PL (1) | PL358180A1 (es) |
| SK (1) | SK16312002A3 (es) |
| SV (1) | SV2002000459A (es) |
| WO (1) | WO2001090057A1 (es) |
| ZA (1) | ZA200208749B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6984756B2 (en) | 2000-05-19 | 2006-01-10 | Eli Lilly And Company | Process for preparing biphenyl compounds |
| EP1296945B1 (en) | 2000-06-13 | 2004-08-04 | Eli Lilly And Company | Sulfonamide derivatives |
| WO2003032974A2 (en) * | 2001-10-12 | 2003-04-24 | Eli Lilly And Company | Use of sulfonamide derivatives as pharmaceuticals compounds |
| WO2005013961A1 (en) * | 2003-07-17 | 2005-02-17 | Eli Lilly And Company | Combination therapy for treatment of cognitive disorders or psychoses |
| WO2008073789A1 (en) * | 2006-12-11 | 2008-06-19 | Eli Lilly And Company | Ampa receptor potentiators |
| CN105579575A (zh) | 2013-06-13 | 2016-05-11 | 维罗技术有限责任公司 | 用于治疗代谢失调的组合物和方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5235599A (en) * | 1998-07-31 | 2000-02-21 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
-
2001
- 2001-05-04 JP JP2001586247A patent/JP2003534316A/ja not_active Withdrawn
- 2001-05-04 BR BR0110874-3A patent/BR0110874A/pt not_active Application Discontinuation
- 2001-05-04 US US10/258,159 patent/US20030225163A1/en not_active Abandoned
- 2001-05-04 CA CA002409830A patent/CA2409830A1/en not_active Abandoned
- 2001-05-04 IL IL15215601A patent/IL152156A0/xx unknown
- 2001-05-04 EA EA200201234A patent/EA200201234A1/ru unknown
- 2001-05-04 SK SK1631-2002A patent/SK16312002A3/sk unknown
- 2001-05-04 PL PL01358180A patent/PL358180A1/xx not_active Application Discontinuation
- 2001-05-04 EP EP01932536A patent/EP1311474A1/en not_active Withdrawn
- 2001-05-04 CN CN01809667A patent/CN1429205A/zh active Pending
- 2001-05-04 DZ DZ013343A patent/DZ3343A1/fr active
- 2001-05-04 MX MXPA02010020A patent/MXPA02010020A/es unknown
- 2001-05-04 WO PCT/US2001/011747 patent/WO2001090057A1/en not_active Ceased
- 2001-05-04 HR HR20020918A patent/HRP20020918A2/hr not_active Application Discontinuation
- 2001-05-04 HU HU0302255A patent/HUP0302255A3/hu unknown
- 2001-05-04 CZ CZ20023797A patent/CZ20023797A3/cs unknown
- 2001-05-04 KR KR1020027015545A patent/KR20030007644A/ko not_active Withdrawn
- 2001-05-04 AU AU2001259053A patent/AU2001259053A1/en not_active Abandoned
- 2001-05-18 SV SV2001000459A patent/SV2002000459A/es not_active Application Discontinuation
- 2001-05-18 PE PE2001000451A patent/PE20020052A1/es not_active Application Discontinuation
- 2001-05-18 EC EC2001004078A patent/ECSP014078A/es unknown
- 2001-05-18 AR ARP010102374A patent/AR035915A1/es unknown
-
2002
- 2002-10-29 ZA ZA200208749A patent/ZA200208749B/en unknown
- 2002-11-14 NO NO20025459A patent/NO20025459D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0110874A (pt) | 2003-02-11 |
| HUP0302255A3 (en) | 2005-11-28 |
| EP1311474A1 (en) | 2003-05-21 |
| AR035915A1 (es) | 2004-07-28 |
| IL152156A0 (en) | 2003-05-29 |
| DZ3343A1 (fr) | 2001-11-29 |
| PE20020052A1 (es) | 2002-02-02 |
| KR20030007644A (ko) | 2003-01-23 |
| ECSP014078A (es) | 2002-02-25 |
| NO20025459L (no) | 2002-11-14 |
| NO20025459D0 (no) | 2002-11-14 |
| CN1429205A (zh) | 2003-07-09 |
| MXPA02010020A (es) | 2003-02-12 |
| WO2001090057A1 (en) | 2001-11-29 |
| CZ20023797A3 (cs) | 2003-04-16 |
| PL358180A1 (en) | 2004-08-09 |
| ZA200208749B (en) | 2004-01-30 |
| HUP0302255A2 (hu) | 2003-11-28 |
| US20030225163A1 (en) | 2003-12-04 |
| AU2001259053A1 (en) | 2001-12-03 |
| SV2002000459A (es) | 2002-07-03 |
| CA2409830A1 (en) | 2001-11-29 |
| EA200201234A1 (ru) | 2003-04-24 |
| SK16312002A3 (sk) | 2003-05-02 |
| JP2003534316A (ja) | 2003-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1246797B1 (en) | Cyclopentyl sulfonamide derivatives | |
| HRP20020918A2 (en) | Sulfonamide derivatives | |
| US6803484B2 (en) | Sulfonamide derivatives | |
| CA2338745A1 (en) | Heterocyclyl sulphonamide derivatives | |
| EP1309577A2 (en) | Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function | |
| US7652064B2 (en) | AMPA receptor potentiators | |
| US6639107B1 (en) | Cyclopentyl sulfonamide derivatives | |
| US20040235957A1 (en) | Use of sulfonamide derivatives as pharmaceuticals compounds | |
| WO2002018329A1 (en) | Acetylenic sulfonamide derivatives | |
| EP1409452A1 (en) | Sulfonamide derivatives | |
| US20040147612A1 (en) | Sulfonamide derivatives | |
| CA2410531A1 (en) | Combination therapy for treatment of depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| OBST | Application withdrawn |